Detalhe da pesquisa
1.
68Ga-labelled recombinant antibody variants for immuno-PET imaging of solid tumours.
Eur J Nucl Med Mol Imaging
; 37(7): 1397-407, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20157706
2.
Inhibition of melanoma growth by targeting of antigen to dendritic cells via an anti-DEC-205 single-chain fragment variable molecule.
Clin Cancer Res
; 14(24): 8169-77, 2008 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19088032
3.
Effect of domain order on the activity of bacterially produced bispecific single-chain Fv antibodies.
J Mol Biol
; 330(1): 99-111, 2003 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-12818205
4.
Single-chain antibodies for the conformation-specific blockade of activated platelet integrin alphaIIbbeta3 designed by subtractive selection from naive human phage libraries.
FASEB J
; 18(14): 1704-6, 2004 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-15522915
5.
Effect of linker sequences between the antibody variable domains on the formation, stability and biological activity of a bispecific tandem diabody.
Protein Eng Des Sel
; 17(4): 357-66, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15126676
6.
Immunosuppressive properties of anti-CD3 single-chain Fv and diabody.
J Immunol Methods
; 285(1): 111-27, 2004 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14871540
7.
Recent advances in the generation of bispecific antibodies for tumor immunotherapy.
Curr Opin Drug Discov Devel
; 7(2): 233-42, 2004 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15603258
8.
Generation and production of engineered antibodies.
Mol Biotechnol
; 26(1): 39-60, 2004 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-14734823
9.
A novel tetravalent bispecific TandAb (CD30/CD16A) efficiently recruits NK cells for the lysis of CD30+ tumor cells.
MAbs
; 6(3): 728-39, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24670809
10.
WITHDRAWN: Tetravalent Bispecific Single-Chain Fv Antibodies for Lysis of Leukemia Cells by Autologous T Cells.
J Mol Biol
; 2012 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-22985968
11.
Effect of tetravalent bispecific CD19xCD3 recombinant antibody construct and CD28 costimulation on lysis of malignant B cells from patients with chronic lymphocytic leukemia by autologous T cells.
Int J Cancer
; 112(3): 509-18, 2004 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-15382079
12.
Synergistic antitumor effect of bispecific CD19 x CD3 and CD19 x CD16 diabodies in a preclinical model of non-Hodgkin's lymphoma.
J Immunol
; 169(1): 137-44, 2002 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12077238